Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating preoperative Lugol's solution in Graves' disease and toxic multinodular goiter; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lugol's solution (potassium iodide solution)

Snippet

Sponsor: Jan Calissendorff | Conditions: Hyperthyroidism | Phase 3 | Status: RECRUITING